trending Market Intelligence /marketintelligence/en/news-insights/trending/yebm4ho7utqizc_k5tmxjw2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Eleven Biotherapeutics regains compliance with Nasdaq listing requirements

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Eleven Biotherapeutics regains compliance with Nasdaq listing requirements

Eleven Biotherapeutics Inc. said it regained compliance with Nasdaq Stock Market LLC's $1 minimum bid price listing requirement.

The Cambridge, Mass.-based company received a noncompliance notice from the Nasdaq in December 2017 as the closing bid price of the company's common stock was below $1 per share for 30 consecutive business days.

Nasdaq confirmed that the company regained compliance after the closing bid price for its common stock had been at $1 per share or greater for a minimum of 10 consecutive business days.